In the last trading session, 5.06 million ABVC BioPharma Inc (NASDAQ:ABVC) shares changed hands as the company’s beta touched 0.26. With the company’s per share price at $0.83 changed hands at $0.09 or 11.86% during last session, the market valuation stood at $10.77M. ABVC’s last price was a discount, traded about -108.43% off its 52-week high of $1.73. The share price had its 52-week low at $0.40, which suggests the last value was 51.81% up since then. When we look at ABVC BioPharma Inc’s average trading volume, we note the 10-day average is 0.98 million shares, with the 3-month average coming to 561.16K.
Analysts gave the ABVC BioPharma Inc (ABVC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ABVC as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. ABVC BioPharma Inc’s EPS for the current quarter is expected to be 0.
ABVC BioPharma Inc (NASDAQ:ABVC) trade information
Instantly ABVC was in green as seen at the end of in last trading. With action -21.70%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 40.68%, with the 5-day performance at -21.70% in the red. However, in the 30-day time frame, ABVC BioPharma Inc (NASDAQ:ABVC) is 29.97% up. Looking at the short shares, we see there were 0.32 million shares sold at short interest cover period of 0.24 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 12.78%.
ABVC Dividends
ABVC BioPharma Inc is expected to release its next quarterly earnings report on 2023-May-14.
ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.95% of ABVC BioPharma Inc shares while 3.89% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.98%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 50.91 shares estimated at $42259.0 under it, the former controlled 0.39% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.36% of the shares, roughly 46.95 shares worth around $38966.0.
